Enliven Therapeutics (ELVN) Earnings Date & Reports

Enliven Therapeutics Inc is a clinical-stage precision oncology company focused on the discovery and development of potentially first-in-class precision oncology therapies... Show more

Get AI intraday signals

A.I. Advisor

published Earnings

ELVN is expected to report earnings to rise 8.76% to -50 cents per share on May 08

Enliven Therapeutics ELVN Stock Earnings Reports

Q1'25

Est.

$-0.50

Q4'24

Beat

by $0.06

Q3'24

Beat

by $0.03

Q2'24

Beat

by $0.14

Q1'24

Est.

$-0.54

The last earnings report on March 13 showed earnings per share of -46 cents, beating the estimate of -51 cents. With 744.65K shares outstanding, the current market capitalization sits at 973.23M.

View a ticker or compare two or three

Compare

ELVN